'We'll see you in court' Sen. Hawley says after publisher cancels publication of his upcoming book
Simon & Schuster "cannot support Senator Hawley after his role in what became a dangerous threat to our democracy and freedom," the company said in a statement.
The Facts Inside Our Reporter’s Notebook
Simon & Schuster announced on Thursday that it is cancelling publication of Sen. Josh Hawley's upcoming book, a move that Hawley has indicated that he will challenge in court.
"After witnessing the disturbing, deadly insurrection that took place on Wednesday in Washington, D.C., Simon & Schuster has decided to cancel publication of Senator Josh Hawley's forthcoming book, THE TYRANNY OF BIG TECH," the company said in a statement. "We did not come to this decision lightly. As a publisher it will always be our mission to amplify a variety of voices and viewpoints; at the same time we take seriously our larger public responsibility as citizens, and cannot support Senator Hawley after his role in what became a dangerous threat to our democracy and freedom."
The Missouri Republican described the move as "Orwellian" and characterized it as an attack against the First Amendment of the U.S. Constitution.
"Simon & Schuster is canceling my contract because I was representing my constituents, leading a debate on the Senate floor on voter integrity, which they have now decided to redefine as sedition," Hawley said in a statement. "Let me be clear, this is not just a contract dispute. It's a direct assault on the First Amendment. Only approved speech can now be published. This is the Left looking to cancel everyone they don't approve of. I will fight this cancel culture with everything I have. We'll see you in court."
News, not Noise
- Effort to spread discredited Russia collusion theory welcomed by McCain Senate panel, memos show
- Draft report of Maricopa audit finds Biden won but flags as many as 44,000 votes as 'critical'
- White House tells agencies to begin preparing for potential government shutdown
- Ten questions the Arizona election audit could answer Friday
- DeSantis sidesteps Biden rationing, acquires new monoclonal antibodies from U.K. drug firm